Russell Investments Group’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $10.6M | Sell |
84,169
-16,429
| -16% | -$2.06M | 0.01% | 831 |
|
2025
Q1 | $11.1M | Sell |
100,598
-25,619
| -20% | -$2.84M | 0.02% | 781 |
|
2024
Q4 | $17.2M | Sell |
126,217
-84,560
| -40% | -$11.5M | 0.02% | 632 |
|
2024
Q3 | $24.3M | Sell |
210,777
-77,984
| -27% | -$8.99M | 0.04% | 508 |
|
2024
Q2 | $39.7M | Sell |
288,761
-60,556
| -17% | -$8.33M | 0.06% | 319 |
|
2024
Q1 | $48.2M | Sell |
349,317
-55,962
| -14% | -$7.72M | 0.08% | 293 |
|
2023
Q4 | $53.4M | Sell |
405,279
-8,564
| -2% | -$1.13M | 0.1% | 234 |
|
2023
Q3 | $46.6M | Buy |
413,843
+13,479
| +3% | +$1.52M | 0.09% | 247 |
|
2023
Q2 | $37.8M | Buy |
400,364
+57,582
| +17% | +$5.43M | 0.07% | 300 |
|
2023
Q1 | $34.7M | Buy |
342,782
+186,397
| +119% | +$18.9M | 0.07% | 347 |
|
2022
Q4 | $18.7M | Buy |
156,385
+34,048
| +28% | +$4.07M | 0.04% | 533 |
|
2022
Q3 | $13M | Sell |
122,337
-29,963
| -20% | -$3.18M | 0.03% | 649 |
|
2022
Q2 | $14.8M | Buy |
152,300
+11,814
| +8% | +$1.15M | 0.03% | 612 |
|
2022
Q1 | $13.2M | Buy |
140,486
+89,615
| +176% | +$8.4M | 0.02% | 714 |
|
2021
Q4 | $4.33M | Buy |
50,871
+16,648
| +49% | +$1.42M | 0.01% | 1340 |
|
2021
Q3 | $3.28M | Buy |
34,223
+12,369
| +57% | +$1.18M | 0.01% | 1507 |
|
2021
Q2 | $2.13M | Buy |
21,854
+4,753
| +28% | +$462K | ﹤0.01% | 1876 |
|
2021
Q1 | $1.66M | Buy |
17,101
+3,070
| +22% | +$298K | ﹤0.01% | 1984 |
|
2020
Q4 | $1.34M | Sell |
14,031
-6,390
| -31% | -$611K | ﹤0.01% | 1970 |
|
2020
Q3 | $1.97M | Sell |
20,421
-58,844
| -74% | -$5.66M | ﹤0.01% | 1700 |
|
2020
Q2 | $9.67M | Sell |
79,265
-29,164
| -27% | -$3.56M | 0.02% | 749 |
|
2020
Q1 | $9.4M | Buy |
108,429
+35,475
| +49% | +$3.07M | 0.02% | 679 |
|
2019
Q4 | $7.84M | Buy |
72,954
+1,605
| +2% | +$172K | 0.01% | 959 |
|
2019
Q3 | $6.43M | Sell |
71,349
-138
| -0.2% | -$12.4K | 0.01% | 1071 |
|
2019
Q2 | $6.04M | Buy |
71,487
+694
| +1% | +$58.6K | 0.01% | 1133 |
|
2019
Q1 | $6.24M | Buy |
70,793
+1,084
| +2% | +$95.5K | 0.01% | 1121 |
|
2018
Q4 | $4.98M | Sell |
69,709
-36,844
| -35% | -$2.63M | 0.01% | 1149 |
|
2018
Q3 | $13.1M | Sell |
106,553
-13,059
| -11% | -$1.61M | 0.02% | 792 |
|
2018
Q2 | $11.7M | Buy |
119,612
+46,978
| +65% | +$4.61M | 0.02% | 813 |
|
2018
Q1 | $6.02M | Buy |
72,634
+7,567
| +12% | +$628K | 0.01% | 1252 |
|
2017
Q4 | $4.91M | Buy |
65,067
+37,192
| +133% | +$2.8M | 0.01% | 1365 |
|
2017
Q3 | $1.71M | Buy |
27,875
+19,518
| +234% | +$1.2M | ﹤0.01% | 1879 |
|
2017
Q2 | $384K | Sell |
8,357
-16,301
| -66% | -$749K | ﹤0.01% | 2513 |
|
2017
Q1 | $1.07M | Sell |
24,658
-2,391
| -9% | -$103K | ﹤0.01% | 2064 |
|
2016
Q4 | $1.03M | Buy |
+27,049
| New | +$1.03M | ﹤0.01% | 2162 |
|